A carregar...
Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study
The optimal sequence of systemic chemotherapy in metastatic breast cancer (MBC) is unknown. We report the case of a woman who was successfully treated with nanoparticle albumin-bound (nab)-paclitaxel for triple negative MBC in our institution. In November 2008, a 48-year-old woman underwent surgical...
Na minha lista:
Publicado no: | Anticancer Drugs |
---|---|
Main Authors: | , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Lippincott Williams & Wilkins
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4243802/ https://ncbi.nlm.nih.gov/pubmed/25115342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000159 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|